Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Accumulation of unwanted/misfolded proteins in aggregates has been observed in airways of patients with cystic fibrosis (CF), a life-threatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). Here we show how the defective CFTR results in defective autophagy and decreases the clearance of aggresomes. Defective CFTR-induced upregulation of reactive oxygen species (ROS) and tissue transglutaminase (TG2) drive the crosslinking of beclin 1, leading to sequestration of phosphatidylinositol-3-kinase (PI(3)K) complex III and accumulation of p62, which regulates aggresome formation. Both CFTR knockdown and the overexpression of green fluorescent protein (GFP)-tagged-CFTR(F508del) induce beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-TG2 pathway. Restoration of beclin 1 and autophagy by either beclin 1 overexpression, cystamine or antioxidants rescues the localization of the beclin 1 interactome to the endoplasmic reticulum and reverts the CF airway phenotype in vitro, in vivo in Scnn1b-transgenic and Cftr(F508del) homozygous mice, and in human CF nasal biopsies. Restoring beclin 1 or knocking down p62 rescued the trafficking of CFTR(F508del) to the cell surface. These data link the CFTR defect to autophagy deficiency, leading to the accumulation of protein aggregates and to lung inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, a large body of evidence indicates that CFTR defects impair autophagy, through mechanisms that include the sequestration of BECN1 (and its interactome) in aggresomes (Luciani et al, 2010; Luciani et al, 2011) and an impairment in xenophagy.”
From Autophagy in major human diseases (2021) · cites this paper as Luciani et al, 2010
In the citing paper
“| Cystic fibrosis | CFTRdel506 transgenic mice | Impaired autophagy through TG2‐mediated BECN1 inhibition | Luciani et al (2010) |”
From Autophagy in major human diseases (2021) · cites this paper as Luciani et al (2010)
Citations
Cites
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 1×
“Autophagy is a cytoprotective mechanism for the degradation of misfolded/polyubiquitylated proteins and damaged organelles through lysosome-mediated self-digestio”
BackgroundSignal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,296 · cited 1×
“S3d ), which associate transiently with the surface of forming autophagosome”
BackgroundMethods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Webb, A. K. (2006) · Cited by 4,369
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,577 · cited 1×
“Discussion Defective autophagy is a critical mechanism in several chronic human disease”
BackgroundBcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536 · cited 1×
“Moreover, dissociation of beclin 1 from Bcl-2 promotes autophagy during stress conditions such as starvatio”
BackgroundBjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276 · cited 1×
“Autophagy is important in clearing protein aggregates after overload of polyubiquitylated protein”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Self-citationImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Cited by
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
“Airway epithelial cells from cystic fibrosis patients and mouse models of the disease have reduced autophagic activity likely because Beclin 1 is sequestered into cytoplasmic aggregates (Luciani et al., 2010).”
BackgroundAutophagy in immunity and inflammation
Levine, B., Mizushima, N., & Virgin, H. W. (2011) · Nature · doi:10.1038/nature09782 · Cited by 3,289
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationPAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,221
“Autophagy is involved in other inflammatory disorders including cystic fibrosis (150), obesity (151), and sepsis (152).”
BackgroundCystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Medina, D. L., Fraldi, A., Bouche, V., Annunziata, F., Mansueto, G., Spampanato, C., Puri, C., Pignata, A., Martina, J. A., Sardiello, M., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.016 · Cited by 716
“Calcium Measurements by Confocal Imaging TFEB-GFP-transfected cells were treated with FuraRed and analyzed according to the protocol described previously (Luciani et al., 2010).”
MethodSelf-citationAutophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
“Restoration of autophagy may be a novel approach to the treatment of CF and may pave the way for the development of a new class of drugs that, by enhancing autophagy or by enhancing BECN1 levels, could be effective treatments for CF.(116)”
BackgroundMaugeri, N., Campana, L., Gavina, M., Covino, C., De Metrio, M., Panciroli, C., Maiuri, L., Maseri, A., D'Angelo, A., Bianchi, M. E., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12710 · Cited by 534
Self-citationEndoplasmic Reticulum Stress in Immunity
Bettigole, S. E., & Glimcher, L. H. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112116 · Cited by 513
Cystic fibrosis: a mucosal immunodeficiency syndrome
Cohen, T. S., & Prince, A. (2012) · Nature Medicine · doi:10.1038/nm.2715 · Cited by 484
Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis
Cadwell, K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.100 · Cited by 475
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Ornatowski, W., Lu, Q., Yegambaram, M., Garcia, A. E., Zemskov, E. A., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101679 · Cited by 467
Autophagy: for better or for worse
Wirawan, E., Berghe, T. V., Lippens, S., Agostinis, P., & Vandenabeele, P. (2012) · Cell Research · doi:10.1038/cr.2011.152 · Cited by 465
Progress in therapies for cystic fibrosis
De Boeck, K., & Amaral, M. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00023-0 · Cited by 451
Autophagy and cellular immune responses
Ma, Y., Galluzzi, L., Zitvogel, L., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.017 · Cited by 447
Transglutaminase Regulation of Cell Function
Eckert, R. L., Kaartinen, M. T., Nurminskaya, M., Belkin, A. M., Colak, G., Johnson, G. V. W., & Mehta, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00019.2013 · Cited by 419
Villella, V. R., Esposito, S., Bruscia, E. M., Maiuri, M. C., Raia, V., Kroemer, G., & Maiuri, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00001 · Cited by 389
Self-citationAutophagy: A Critical Regulator of Cellular Metabolism and Homeostasis
Ryter, S. W., Cloonan, S. M., & Choi, A. M. K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0140-8 · Cited by 385
“Alzheimer’s disease may be associated with autophagic dysfunction, as evidenced by increased autophagosome number in human brains with Alzheimer’s disease (Ma et al., 2010).”
BackgroundAutophagy in Idiopathic Pulmonary Fibrosis
Patel, A. S., Lin, L., Geyer, A., Haspel, J. A., An, C. H., Cao, J., Rosas, I. O., & Morse, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041394 · Cited by 372
Salminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J., Haapasalo, A., Soininen, H., & Hiltunen, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 364
Vij, N., Chandramani-Shivalingappa, P., Van Westphal, C., Hole, R., & Bodas, M. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00110.2016 · Cited by 329
“The autophagy-inducing effect of cysteamine/cystamine is known to involve its ability to not only control ROS activity but also restore BECN1 (beclin-1) and p62 (sequestesome-1) levels (11, 12, 29, 30).”
BackgroundAutophagy and inflammation in ischemic stroke
Liu, K.-Y., Mo, Y., & Sun, Y.-Y. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274331 · Cited by 322
“Some drugs, such as dexmedetomidine, protect against I/R-damaged neurons during reperfusion by promoting autophagy (Luo et al., 2017).”
BackgroundQian, M., Fang, X., & Wang, X. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0154-5 · Cited by 316
“Both CFTR knockdown and the overexpression of GFP-tagged-CFTRF508del induce Beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-tissue transglutaminase pathway [90].”
BackgroundThe clearance of dying cells: table for two
Green, D. R., Oguin, T. H., & Martinez, J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.172 · Cited by 314
Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology
Cheng, Y., Ren, X., Hait, W. N., & Yang, J.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007120 · Cited by 262
“Another connection between autophagy and chronic inflammation was found in cystic fibrosis, a lifethreatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) (Luciani et al., 2010).”
BackgroundInfluentialRegulation of autophagy by Beclin 1 in the heart
Maejima, Y., Isobe, M., & Sadoshima, J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.032 · Cited by 247
“An increasing number of experimental Beclin 1 gene therapy studies suggest that modulation of Beclin 1 activity could be therapeutically beneficial in a cystic fibrosis model [68], collagen VI muscular dystrophy models [69], an alpha-synuclein model of Parkinson’s disease [70] and a spinocerebellar ataxia type 3 disea…”
Fujii, S., Hara, H., Araya, J., Takasaka, N., Kojima, J., Ito, S., Minagawa, S., Yumino, Y., Ishikawa, T., Numata, T., et al. (2012) · OncoImmunology · doi:10.4161/onci.20297 · Cited by 243
Cellular Functions of Tissue Transglutaminase
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00001-x · Cited by 235
“The TG2-induced cross-linking of beclin 1 led to sequestration of its interactome in aggresomes in CFTR-deficient epithelial cells under conditions of oxidative stress (Luciani et al., 2010).”
BackgroundChloride in Vesicular Trafficking and Function
Stauber, T., & Jentsch, T. J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183702 · Cited by 216
Oxidative stress and antioxidant therapy in cystic fibrosis
Galli, F., Battistoni, A., Gambari, R., Pompella, A., Bragonzi, A., Pilolli, F., Iuliano, L., Piroddi, M., Dechecchi, M. C., & Cabrini, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.012 · Cited by 214
Role of ion channels in gastrointestinal cancer
Anderson, K. J., Cormier, R. T., & Scott, P. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i38.5732 · Cited by 200
Abdulrahman, B. A., Khweek, A. A., Akhter, A., Caution, K., Kotrange, S., Abdelaziz, D. H. A., Newland, C., Rosales-Reyes, R., Kopp, B., McCoy, K., et al. (2011) · Autophagy · doi:10.4161/auto.7.11.17660 · Cited by 190
“cepacia-mediated downregulation of autophagy genes is similar in WT and ΔF508 macrophages but the effect is more pronounced in the latter cells suggesting that they harbor an inefficient autophagy system as described in ΔF508 epithelial cells.(11,12) Depletion of LC3 from WT macrophages allows for more B.”
BackgroundInfluentialCFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Lopes-Pacheco, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00275 · Cited by 180
“Among the quality control systems, ubiquitin-proteasome pathway destroys the largest fraction of misfolded CFTR (Cheng et al., 1990; Jensen et al., 1995), and aggresomes degrade by autophagy CFTR molecules that proteasomes cannot degrade (Kawaguchi et al., 2003; Luciani et al., 2010).”
BackgroundExploring the Role of Staphylococcus aureus in Inflammatory Diseases
Chen, H., Zhang, J., He, Y., Lv, Z., Liang, Z., Chen, J., Li, P., Liu, J., Yang, H., Tao, A., et al. (2022) · Toxins · doi:10.3390/toxins14070464 · Cited by 179
Wei, K., Wang, P., & Miao, C. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12005 · Cited by 181
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.004 · Cited by 173
Inhibition of MTOR Disrupts Autophagic Flux in Podocytes
Cinà, D. P., Onay, T., Paltoo, A., Li, C., Maezawa, Y., De Arteaga, J., Jurisicova, A., & Quaggin, S. E. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070690 · Cited by 172
Autophagosome–lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL
De Leo, M. G., Staiano, L., Vicinanza, M., Luciani, A., Carissimo, A., Mutarelli, M., Di Campli, A., Polishchuk, E., Di Tullio, G., Morra, V., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3386 · Cited by 165
Self-citationHan, S., Gao, H., Chen, S., Wang, Q., Li, X., Du, L.-J., Li, J., Luo, Y.-Y., Li, J.-X., Zhao, L.-C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51614-x · Cited by 163
Cystic Fibrosis Lung Immunity: The Role of the Macrophage
Bruscia, E. M., & Bonfield, T. L. (2016) · Journal of Innate Immunity · doi:10.1159/000446825 · Cited by 163
Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells
Ceccariglia, S., Cargnoni, A., Silini, A. R., & Parolini, O. (2020) · Autophagy · doi:10.1080/15548627.2019.1630223 · Cited by 161
“Numerous studies demonstrate that deregulated autophagy is linked to neurodegenerative disorders [12], cystic fibrosis [13], myopathies [14] and cardiomyopathy [15].”
BackgroundImpaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney
Festa, B. P., Chen, Z., Berquez, M., Debaix, H., Tokonami, N., Prange, J. A., Hoek, G. V. D., Alessio, C., Raimondi, A., Nevo, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02536-7 · Cited by 158
Self-citationYang, H.-Z., Wang, J.-P., Mi, S., Liu, H.-Z., Cui, B., Yan, H.-M., Yan, J., Li, Z., Liu, H., Hua, F., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.019 · Cited by 155
“46,47 Thus our results highlight a course of action in which immunostimulants with autophagy-en-hancing activity, rather than immunosuppressive agents, should be used for the treatment of fibroprolif-erative diseases.”
BackgroundTatsukawa, H., Furutani, Y., Hitomi, K., & Kojima, S. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.150 · Cited by 171
Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy
Lubamba, B., Dhooghe, B., Noël, S., & Leal, T. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.05.034 · Cited by 204
“Candidate drugs that specifically increase the residence time of CFTR protein in the apical membrane have not yet been clearly identified but studies on modulation of endocytic activity of misfolded integral proteins with formation of intracellular aggregates and autophagy, as well as the consequences of these deregul…”
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
Stefano, D. D., Villella, V. R., Esposito, S., Tosco, A., Sepe, A., Gregorio, F. D., Salvadori, L., Grassia, R., Leone, C. A., Rosa, G. D., et al. (2014) · Autophagy · doi:10.4161/15548627.2014.973737 · Cited by 148
“S7).(26) These effects were largely lost after 48 h of cysteamine withdrawal, unless EGCG was added to the system (Fig.”
BackgroundMethodInfluentialSelf-citationWang, Y., Yuan, Q., Feng, W., Pu, W., Ding, J., Zhang, H., Li, X., Yang, B., Dai, Q., Cheng, L., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0537-4 · Cited by 138
Autophagy in lung disease pathogenesis and therapeutics
Ryter, S. W., & Choi, A. M. K. (2015) · Redox Biology · doi:10.1016/j.redox.2014.12.010 · Cited by 135
Mitochondrial dysfunction in lung ageing and disease
Cloonan, S. M., Kim, K., Estèves, P., Trian, T., & Barnes, P. J. (2020) · European Respiratory Review · doi:10.1183/16000617.0165-2020 · Cited by 147
Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress
Janda, E., Isidoro, C., Carresi, C., & Mollace, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8318-1 · Cited by 140
“TG2-driven cross-linking of Beclin-1 inactivates the Beclin-Vps34 complex and prevents autophagosome formation [193].”
BackgroundAutophagy and inflammatory diseases
Jones, S. A., Mills, K. H. G., & Harris, J. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2012.82 · Cited by 136
Carloni, S., Favrais, G., Saliba, E., Albertini, M. C., Chalon, S., Longini, M., Gressens, P., Buonocore, G., & Balduini, W. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12354 · Cited by 124
The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation
Lin, H., Li, S., & Shu, H.-B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01751 · Cited by 124
“Defective CFTR triggers aggresome formation and lung inflammation in cystic fibrosis (CF) by ROS-TG2-BECN1mediated inhibition of autophagy (99, 100).”
BackgroundOmenetti, A., Carta, S., Delfino, L., Martini, A., Gattorno, M., & Rubartelli, A. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202774 · Cited by 138
Autophagy in T‐cell development, activation and differentiation
Bronietzki, A. W., Schuster, M., & Schmitz, I. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.81 · Cited by 121
Bodas, M., Westphal, C. V., Carpenter-Thompson, R., Mohanty, D. K., & Vij, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.017 · Cited by 128
“Thus we concluded that WPSE and nicotine mediated ROS activation (Figure 3C) results in aggregation of misfolded-proteins as aggresome-bodies [53].”
BackgroundThe Emerging Importance of Autophagy in Pulmonary Diseases
Mizumura, K., Cloonan, S. M., Haspel, J. A., & Choi, A. M. K. (2012) · CHEST Journal · doi:10.1378/chest.12-0809 · Cited by 126
Ion channels in the regulation of autophagy
Kondratskyi, A., Kondratska, K., Skryma, R. N., Klionsky, D. J., & Prevarskaya, N. B. (2017) · Autophagy · doi:10.1080/15548627.2017.1384887 · Cited by 124
“nase 2) leading to crosslinking of BECN1, sequestration of PtdIns3K complex III and accumulation of SQSTM1.(188) These results suggest that CFTR positively regulates autophagy.”
BackgroundInfluentialHypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model
Yang, Z., Zhong, L., Zhong, S., Xian, R., & Yuan, B. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.02.003 · Cited by 123
El-Awady, A. R., Miles, B., Scisci, E., Kurago, Z. B., Palani, C. D., Arce, R. M., Waller, J. L., Genco, C. A., Slocum, C., Manning, M., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004647 · Cited by 115
“Several lines of evidence have emerged linking autophagy and chronic inflammatory diseases [1,61,62].”
BackgroundRyter, S. W., Bhatia, D., & Choi, M. E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7518 · Cited by 114
Autophagy: A Crucial Moderator of Redox Balance, Inflammation, and Apoptosis in Lung Disease
Nakahira, K., Cloonan, S. M., Mizumura, K., Choi, A. M. K., & Ryter, S. W. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5373 · Cited by 112
“TG2 results in the crosslinking and inactivation of Beclin 1, leading to sequestration of PI3KC3 and accumulation of p62 (103).”
BackgroundRedox control of NLRP3 inflammasome activation in health and disease
Rubartelli, A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512265 · Cited by 112
“In fact, redox alterations are found in several genetic diseases [64–68].”
BackgroundPPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases
de Carvalho, M. V., Gonçalves-de-Albuquerque, C. F., & Silva, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020805 · Cited by 120
“A deletion of phenylalanine 508 (F508) affects a high percentage of patients and results in inflammation and other alterations [101,102].”
BackgroundRole of Transglutaminase 2 in Cell Death, Survival, and Fibrosis
Tatsukawa, H., & Hitomi, K. (2021) · Cells · doi:10.3390/cells10071842 · Cited by 127
“Finally, TG2 is stabilized by SUMOylation, which inhibits TG2 ubiquitination, leading to enhanced protein levels and activity [83,84].”
BackgroundAnimal Models in the Pathophysiology of Cystic Fibrosis
Semaniakou, A., Croll, R. P., & Chappe, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01475 · Cited by 151
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Romani, L. R., Oikonomou, V., Moretti, S., Iannitti, R. G., D’Adamo, M. C., Villella, V. R., Pariano, M., Sforna, L., Borghi, M., Bellet, M. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4305 · Cited by 108
Self-citationConrad, C., Lymp, J. F., Thompson, V., Dunn, C. E., Davies, Z. A., Chatfield, B. A., Nichols, D. P., Clancy, J. P., Vender, R. L., Egan, M. E., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.08.008 · Cited by 111
“Luciani and colleagues demonstrated an autophagic pathway for intracellular trafficking dependent upon CFTR function that was restored by NAC treatment and allowed for normal CFTR maturation and trafficking to the cell surface [34,35].”
BackgroundAutophagy in Pulmonary Diseases
Ryter, S. W., Nakahira, K., Haspel, J. A., & Choi, A. M. K. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153348 · Cited by 108
Zhang, P., Cheng, J., Zou, S., D’Souza, A. D., Koff, J. L., Lü, J., Lee, P. J., Krause, D. S., Egan, M. E., & Bruscia, E. M. (2015) · Nature Communications · doi:10.1038/ncomms7221 · Cited by 106
Autophagy markers as mediators of lung injury-implication for therapeutic intervention
Vishnupriya, S., Dharshini, L. C. P., Sakthivel, K. M., & Rasmi, R. R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118308 · Cited by 112
Király, R., Demény, M. Á., & Fésüs, L. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08345.x · Cited by 113
Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury
Bodas, M., Min, T., & Vij, N. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00408.2010 · Cited by 99
Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung Infection
Junkins, R. D., Shen, A., Rosen, K. V., McCormick, C., & Lin, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072263 · Cited by 108
“Autophagy represents an evolutionarily conservedmechanism for the clearance of intracellular pathogens, and recent reports have shown the pathway to be dysregulated in the lungs of cystic fibrosis patients [14].”
BackgroundInfluentialLuciani, A., Villella, V. R., Esposito, S., Gavina, M., Russo, I., Silano, M., Guido, S., Pettoello‐Mantovani, M., Carnuccio, R., Scholte, B. J., et al. (2012) · Autophagy · doi:10.4161/auto.21483 · Cited by 113
Self-citationMacrophage-derived MCPIP1 mediates silica-induced pulmonary fibrosis via autophagy
Liu, H., Fang, S., Wang, W., Cheng, Y., Zhang, Y., Liao, H., Yao, H., & Chao, J. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0167-z · Cited by 95
“Autophagy appears to be involved in the development of several lung diseases, such as chronic obstructive pulmonary disease (COPD) [19], cystic fibrosis (CF) [20], pulmonary arterial hypertension (PAH) [21], lung cancer [22] and idiopathic pulmonary fibrosis (IPF) [23].”
BackgroundJessop, F., Hamilton, R. F., Rhoderick, J. F., Shaw, P. K., & Holian, A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.08.029 · Cited by 94
“On the other hand, autophagy is reportedly decreased in bleomycin-induced fibrosis in vivo, and in human Idiopathic Pulmonary Fibrosis and Cystic Fibrosis (10, 11).”
Cystic Fibrosis, CFTR, and Colorectal Cancer
Scott, P. M., Anderson, K., Singhania, M., & Cormier, R. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082891 · Cited by 107
“TG2 cross-linking activity results in key autophagy proteins being bound up in aggresomes [119].”
BackgroundRiquelme, S. A., Lozano, C., Moustafa, A. M., Liimatta, K., Tomlinson, K. L., Britto, C. J., Khanal, S., Gill, S. K., Narechania, A., Azcona, J. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4634 · Cited by 97
“INTRODUCTION The pulmonary pathology associated with cystic fibrosis (CF) consists of dysregulated airway inflammation and excess reactive oxygen species (ROS) that fail to eradicate infection, typically due to Pseudomonas aeruginosa, in over 70% of patients (1, 2).”
BackgroundTosco, A., De Gregorio, F., Esposito, S., De Stefano, D., Sana, I., Ferrari, E., Sepe, A., Salvadori, L., Buonpensiero, P., Di Pasqua, A., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.22 · Cited by 92
“Western blot was performed as previously described20 with antibodies against the following proteins: BECN1, CFTR, β actin, SQSTM1/p62.”
BackgroundMethodInfluentialSelf-citationFusco, C., Micale, L., Egorov, M., Monti, M., D’Addetta, E. V., Augello, B., Cozzolino, F., Calcagnì, A., Fontana, A., Polishchuk, R. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040440 · Cited by 92
“Accumulation of polyubiquitinated protein aggregates is a hallmark of several neurodegenerative disorders as well as of a number of other protein aggregation diseases affecting muscles, heart, liver and lung [36,37].”
BackgroundTargeting autophagy as a potential therapeutic approach for melanoma therapy
Liu, H., He, Z., & Simon, H. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.008 · Cited by 99
“diseases [24-26], pulmonary diseases [27-29], and cancer [30-32].”
BackgroundGlycoprotein folding and quality-control mechanisms in protein-folding diseases
Ferris, S. P., Kodali, V. K., & Kaufman, R. J. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014589 · Cited by 117
“5 (Luo et al., 2006), Uggt1-null embryos die at E10.”
Ratjen, F. A., Waters, V. J., Klingel, M. L., McDonald, N., Dell, S., Leahy, T. R., Yau, Y. C. W., & Grasemann, H. (2015) · European Respiratory Journal · doi:10.1183/13993003.01390-2015 · Cited by 90
Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin‐1–Syk and p62/SQSTM1
Lee, H., Yuk, J., Kim, K., Jang, J., Kang, G., Park, J. B., Son, J., & Jo, E. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.72 · Cited by 90
Novotny, L. A., Amer, A. O., Brockson, M. E., Goodman, S. D., & Bakaletz, L. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067629 · Cited by 89
“This inherent weak autophagy [16–18] is further augmented by the ability of B.”
BackgroundLack of autophagy induces steroid-resistant airway inflammation
Suzuki, Y., Maazi, H., Sankaranarayanan, I., Lam, J., Khoo, B., Soroosh, P., Barbers, R. G., Ou, J.-H. J., Jung, J. U., & Akbari, O. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.09.033 · Cited by 92
Autophagy in airway diseases: a new frontier in human asthma?
Zeki, A. A., Yeganeh, B., Kenyon, N. J., Post, M., & Ghavami, S. (2015) · Allergy · doi:10.1111/all.12761 · Cited by 90
Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)
Bachetti, T., Chiesa, S., Castagnola, P., Bani, D., Zanni, E. D., Omenetti, A., D’Osualdo, A., Fraldi, A., Ballabio, A., Ravazzolo, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201952 · Cited by 96
“Effect of mutant TNFR1 proteins on autophagy Defective clearance of misfolded proteins may lead to further accumulation of intracellular proteins and subsequent inflammation, as has been observed with mutant cystic fibrosis transmembrane conductance regulator (CFTR) proteins.(28) Moreover, animal models suggest that a…”
BackgroundSelf-citationTargeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Reilly, R., Mroz, M. S., Dempsey, E., Wynne, K. J., Keely, S. J., McKone, E. F., Hiebel, C., Behl, C., & Coppinger, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-06588-z · Cited by 99
Autophagy in Pulmonary Diseases
Nakahira, K., Pabon Porras, M. A., & Choi, A. M. K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2468so · Cited by 78
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
Venditto, V. J., Haydar, D., Abdel‐Latif, A., Gensel, J. C., Anstead, M., Pitts, M. G., Creameans, J. W., Kopper, T. J., Peng, C., & Feola, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.574425 · Cited by 99
Liu, H., Cheng, Y., Yang, J., Wang, W., Fang, S., Zhang, W., Han, B., Zhou, Z., Yao, H., Chao, J., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.78 · Cited by 84
Molecular machinery of macroautophagy and its deregulation in diseases
Wong, A. S. L., Cheung, Z. H., & Ip, N. Y. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.005 · Cited by 102
“(CFTR) gene, mutations in CFTR result in mislocalization of the Beclin 1/PI3K complex and inhibit macroautophagy in lung epithelial cells [15].”
BackgroundInfluentialFarinha, C. M., Matos, P., & Amaral, M. D. (2013) · FEBS Journal · doi:10.1111/febs.12392 · Cited by 101
Emergent Properties of Proteostasis in Managing Cystic Fibrosis
Balch, W. E., Roth, D. M., & Hutt, D. M. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004499 · Cited by 81
Guan, X., Qian, Y., Shen, Y., Zhang, L., Du, Y., Dai, H., Qian, J., & Yan, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374071 · Cited by 80
Luo, L., Sun, Z., Zhang, L., Li, X., Dong, Y., & Liu, T. C. (2012) · Lasers in Medical Science · doi:10.1007/s10103-012-1133-0 · Cited by 82
“Evidence has suggested that increased ROS plays an important role in the formation of fibroses of the lung, liver, kidneys, heart, and skeletal muscle [8–12].”
Metadata
- Authors
- Luciani, A., Villella, V. R., Esposito, S., Brunetti-Pierri, N., Medina, D., Settembre, C., Gavina, M., Pulze, L., Giardino, I., Pettoello-Mantovani, M., D'Apolito, M., Guido, S., Masliah, E., Spencer, B., Quaratino, S., Raia, V., Ballabio, A., & Maiuri, L.
- Affiliations
- IRCCS Ospedale San Raffaele (IT)
- University of Naples Federico II (IT)
- University of Foggia (IT)
- Telethon Institute Of Genetics And Medicine (IT)
- University of California San Diego (US)
- Cancer Research UK (GB)
- Federico II University Hospital (IT)
- Corresponding author
- Raia, Valeria
- Ballabio, Andrea
- Maiuri, Luigi
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2010-08-15
- Volume
- 12
- Issue
- 9
- Pages
- 863-875
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2090953360
- Cited by
- 467
- References
- 68
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 30 · 2020: 41 · 2019: 44 · 2018: 35 · 2017: 28 · 2016: 45 · 2015: 37 · 2014: 33 · 2013: 31 · 2012: 38
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-02-23)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- cystic fibrosis, CFTR, aggresomes, autophagy, reactive oxygen species, tissue transglutaminase, Beclin-1, p62, protein aggregation, lung inflammation, endoplasmic reticulum, cystamine, airway epithelium, protein misfolding
- MeSH terms
- Beclin-1, Sequestosome-1 Protein, Phosphoinositide-3 Kinase Inhibitors, Protein Glutamine gamma Glutamyltransferase 2, Acetylcysteine, Adolescent, Adult, Animals, Antioxidants, Autophagy, Cell Line, Cystamine, Cystic Fibrosis, Heat-Shock Proteins, Humans, Inflammation, Membrane Proteins, Mice, Inbred Strains, Mice, Transgenic, Microtubule-Associated Proteins, Models, Biological, Nasal Polyps, Organometallic Compounds, Protein Binding, Transglutaminases, Salicylates, Reactive Oxygen Species, Mice, Inbred CFTR, Cystic Fibrosis Transmembrane Conductance Regulator, GTP-Binding Proteins, Phosphatidylinositol 3-Kinases, Respiratory Mucosa, Protein Transport, Small Ubiquitin-Related Modifier Proteins, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice, Epithelial Sodium Channels, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.